Lifeboat Foundation

It turns out the gut is full of surprises. And one of those surprises may have offered up a key for unlocking a new way of treating multiple sclerosis (MS). Investigators from Brigham and Women’s Hospital have discovered a microRNA—a small RNA molecule—that increases during peak disease in a mouse model of MS and in untreated MS patients. When a synthetic version of the microRNA was orally given to the mice, it prevented disease. While several steps remain before these insights can be translated into therapy for patients, the researchers describe their results as both exciting and unexpected. Their findings are published in Cell Host & Microbe.

“We’ve discovered a new mechanism to regulate the microbiome and treat human disease that hadn’t been known before,” said senior author Howard Weiner, MD, co-director of the Ann Romney Center for Neurologic Diseases at the Brigham. “The gut microbiome is known to play an important role in MS and other diseases. Our findings, which show that a microRNA can be used to target and influence the microbiome with precision, may have applicability for MS and many other diseases, including diabetes, ALS, obesity and cancer.”

Weiner, lead author Shirong Liu, MD, Ph.D., an instructor in the Weiner laboratory, and their colleagues investigated how the altered gut microbiome affects the course of MS. To do so, they studied the microbiome and microRNAs found in the experimental autoimmune encephalomyelitis (EAE) model of MS. Unexpectedly, they found that when they transferred fecal matter from EAE mice at peak disease, it protected the mice who received the transfer. The team found that a specific microRNA, known as miR-30d, rather than live bacteria, was responsible for preventing disease. The investigators found that miR-30d is enriched in untreated, relapsing-remitting MS patients as well.

In Technion, Bar-Ilan trials, nanochip ferries ‘neural growth factor’ — which combats neurodegenerative diseases — and releases it where needed, overcoming blood-brain barrier.

University of Edinburgh tested 1000 people aged 70 for memory, problem solving, thinking speed and general thinking ability — the same people were tested every three years until they reached 79.

New research in mice finds that blocking a key molecule can slow the progression of multiple sclerosis. The findings pave the way for new treatments.

New research highlights the importance of a diet rich in fruit, vegetables, and whole grains for preventing cognitive decline later in life.

A new study finds that gut bacteria from old mice can help rejuvenate the neurons of younger ones, suggesting that gut bacteria are key to aging.

A sage extract has been clinically shown to increase memory performance in older adults by 60%. Measures of attention improved 2.5-fold within hours of ingestion.

By Michael Downey

Why you feel like you’re falling when going to sleep?

A livestreamed event at 8 p.m. PT will offer a look at the startup’s progress developing a “brain-machine interface.”